WEC
ZBH icon

Winslow Evans & Crocker’s Zimmer Biomet ZBH Stock Holding History

Winslow Evans & Crocker’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$65K Buy
434
+412
+1,873% +$58.2K 0.01% 537
2020
Q3 		$3K Hold
22
– – ﹤0.01% 977
2020
Q2 		$3K Sell
22
-1
-4% -$115 ﹤0.01% 1004
2020
Q1 		$4K Hold
23
– – ﹤0.01% 955
2019
Q4 		$4K Hold
23
– – ﹤0.01% 1049
2019
Q3 		$4K Hold
23
– – ﹤0.01% 1040
2019
Q2 		$4K Hold
23
– – ﹤0.01% 1036
2019
Q1 		$4K Hold
23
– – ﹤0.01% 1066
2018
Q4 		$4K Hold
23
– – ﹤0.01% 979
2018
Q3 		$4K Hold
23
– – ﹤0.01% 987
2018
Q2 		$4K Sell
23
-41
-64% -$4.46K ﹤0.01% 1000
2018
Q1 		$6.76K Hold
64
– – ﹤0.01% 863
2017
Q4 		$7.48K Sell
64
-107
-63% -$12.1K ﹤0.01% 861
2017
Q3 		$19.4K Sell
171
-381
-69% -$44K 0.01% 672
2017
Q2 		$68.8K Sell
552
-181
-25% -$21.5K 0.02% 493
2017
Q1 		$86.8K Sell
733
-429
-37% -$48.6K 0.03% 438
2016
Q4 		$116K Sell
1,162
-231
-17% -$24.8K 0.04% 377
2016
Q3 		$176K Buy
1,393
+1,024
+278% +$127K 0.05% 312
2016
Q2 		$43K Sell
369
-40
-10% -$4.53K 0.01% 547
2016
Q1 		$42.3K Sell
409
-50
-11% -$4.84K 0.01% 540
2015
Q4 		$45.8K Buy
459
+14
+3% +$1.37K 0.01% 553
2015
Q3 		$40.5K Buy
445
+78
+21% +$7.82K 0.01% 552
2015
Q2 		$38.9K Buy
367
+221
+151% +$24.5K 0.01% 603
2015
Q1 		$16.7K Hold
146
– – ﹤0.01% 767
2014
Q4 		$16.1K Hold
146
– – ﹤0.01% 784
2014
Q3 		$14.3K Hold
146
– – ﹤0.01% 818
2014
Q2 		$14.7K Hold
146
– – ﹤0.01% 748
2014
Q1 		$13.4K Hold
146
– – ﹤0.01% 767
2013
Q4 		$14K Buy
+146
New +$12.6K ﹤0.01% 812

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Winslow Evans & Crocker's ZBH Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Zimmer Biomet (ZBH) stake by 1,873% in Q4 2020, buying an estimated $58.2K and bringing the position to 434 shares worth $65K. The position accounts for 0.01% of the portfolio, ranked #537.

Winslow Evans & Crocker first reported a position in ZBH in Q4 2013 and has held it in 29 quarters since. The position peaked at $176K in Q3 2016. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Winslow Evans & Crocker held 434 shares of Zimmer Biomet worth $65K as of Q4 2020.
  • Winslow Evans & Crocker bought 412 Zimmer Biomet shares in Q4 2020, an estimated $58.2K.
  • Zimmer Biomet made up 0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #537 holding.
  • Winslow Evans & Crocker first reported a position in Zimmer Biomet in Q4 2013 and has held it in 29 quarters since.
  • Winslow Evans & Crocker's Zimmer Biomet position peaked at $176K in Q3 2016.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.